Asx vti

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech.

Asx vti

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients. Scott Phillips just released his 5 best stocks to buy right now and you could grab the names of these stocks instantly! Skip to content. Fundamentals Data provided by Morningstar. Data provided by Morningstar. Dividend Yield 0. Shares Outstanding Earnings per share Year To Date Return Franking -. Share Price.

Card Details Edit. Thank you for registering. Click for restrictions.

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership. Please contact Member Services on support investsmart.

Key events shows relevant news articles on days with large price movements. Inhalerx Ltd. IRX 2. Uscom Ltd. UCM Hera Med Ltd. HMD Universal Biosensors, Inc.

Asx vti

With the business potentially at an important milestone, we thought we'd take a closer look at Visioneering Technologies, Inc. Visioneering Technologies, Inc. As path to profitability is the topic on Visioneering Technologies' investors mind, we've decided to gauge market sentiment. See our latest analysis for Visioneering Technologies. Expectations from some of the Australian Medical Equipment analysts is that Visioneering Technologies is on the verge of breakeven. So, the company is predicted to breakeven approximately 2 years from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. Should the business grow at a slower rate, it will become profitable at a later date than expected. We're not going to go through company-specific developments for Visioneering Technologies given that this is a high-level summary, however, bear in mind that typically a high forecast growth rate is not unusual for a company that is currently undergoing an investment period. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

Cletus cassidy

Shares Outstanding Please select a quantity for at least one ticket. We look forward to helping you build a market beating stock portfolio. Financial Health. Nov An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Compare our membership packages. An account with your email already exists. Start investing. A verification email has been sent.

Financial Times Close.

Appendix 4E and Annual Financial Report. Feb All markets data located on FT. Issuer Services. Day Change. Lawrence Gozlan , 0. Please make sure your payment details are up to date to continue your membership. Sep Refresh Data. VTI Related Research.